Keyphrases
Anticoagulants
12%
Blood Biomarkers
12%
Blood Samples
12%
Blood-based
100%
Circulating Blood
100%
Circulating microRNA
12%
Clinical Conditions
12%
Clinical Trials
12%
Collection Tubes
62%
Collections Storage
12%
Confounding Variables
12%
EDTA-citrate
12%
Expression Change
12%
Freeze-thaw Cycles
37%
Healthy Donors
12%
Incubation
12%
Lithium Heparin
25%
Long-term Storage
12%
Methodological Considerations
100%
MicroRNA
100%
MicroRNA Quantification
12%
MicroRNA Stability
12%
MicroRNA-1 (miR-1)
50%
MicroRNA-21 (miR-21)
62%
MiR-29b
50%
Non-invasive Biomarkers
12%
Physical Disturbance
37%
Plasma Samples
25%
Preanalytical Phase
100%
Predictive Biomarker
12%
Processing Time
12%
Prognostic Biomarker
12%
Research Conditions
12%
Room Temperature
25%
Sample Preparation
12%
Sample Storage
12%
Separated Fractions
12%
Serum Samples
12%
Systematic Sample
12%
Therapeutic Target
12%
Whole Blood
50%
Whole Blood Sample
12%
Immunology and Microbiology
Blood Plasma
100%
Ethylenediaminetetraacetic Acid
33%
Freeze Thawing
100%
Room Temperature
66%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
11%
Biological Marker
22%
Clinical Trial
11%
Ethylenediaminetetraacetic Acid
11%
Heparin
22%
microRNA
100%
microRNA 1
44%
microRNA 29b
44%